Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · IEX Real-Time Price · USD
2.450
-0.120 (-4.67%)
At close: Jul 19, 2024, 4:00 PM
2.050
-0.400 (-16.33%)
Pre-market: Jul 22, 2024, 4:21 AM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $8.32 million as of July 22, 2024. Its market cap has decreased by -45.96% in one year.
Market Cap
8.32M
Enterprise Value
7.59M
1-Year Change
-45.96%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $8.32M, a decrease of -91.96%. That is a compound annual growth rate of -50.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 7.90M | -46.98% |
| Dec 29, 2023 | 14.90M | 60.22% |
| Dec 30, 2022 | 9.30M | -82.05% |
| Dec 31, 2021 | 51.80M | -49.90% |
| Dec 31, 2020 | 103.40M | -0.12% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Templates | 9.09M |
| NLS Pharmaceutics AG | 9.07M |
| Cyclerion Therapeutics | 8.97M |
| Bionomics | 8.94M |
| Organovo Holdings | 8.74M |
| Virpax Pharmaceuticals | 8.50M |
| Kineta | 8.48M |
| Syra Health | 8.41M |